SARS-CoV-2 Mpro

W-W Zhou1, D-S Li, Y Chen

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. liyan@imb.pumc.edu.cn.

概括

研究人员使用高通量查确定了四种低毒性SARS-CoV-2 Mpro抑制剂. 化合物IMB63-8G显示出显著的抗病毒功效和有利的药物相似性,突出了其在COVID-19治疗中的治疗潜力.